OpenAI IPO filing hits $850bn valuation as chip stocks bounce: Wall Street tests demand
With OpenAI, Anthropic, and SpaceX all lining up, markets are about to price the next AI mega-listing risk.

OpenAI confidentially filed for an IPO on the US stock market, putting its current valuation at $850bn, even as markets swing back to AI. The timing matters for decision-makers because new mega-listings test whether investors will keep funding the infrastructure-heavy, high-expectation AI trade.
Wall Street is trying to catch its breath, and then it gets slapped with one of the biggest words in markets: IPO. OpenAI has confidentially filed for an initial public offering on the US stock market, and the broader AI trade is bouncing back. In the same breath, the coverage points to a key market tension: chip stocks are bouncing, the pound is strengthening, and calm returns to trading, but the test is demand for yet another “superheavyweight” listing.
To understand why investors are suddenly paying attention to filings again, you have to track the valuations and the competitive pressure. OpenAI is currently valued at $850bn, while Anthropic is now valued ahead of OpenAI at $965bn. That gap is not just trivia. It signals that the market is willing to value AI leadership at extreme levels, but it is also sharpening the question of who is “winning” and who is merely “staying in the game.” The filing arrives as OpenAI’s early advantage, helped by a deal with Microsoft, is being challenged by Anthropic, which has gained ground via reams of enterprise contracts.
The money behind the hype is the part executives and board members should care about most: the cost structure. The coverage estimates OpenAI is spending more than $100 billion a year on infrastructure and processing power to support its services and power the next generation of AI models. That number is the whole game. High valuations are easy when expectations are forward-looking. High valuations become harder when execution requires constant spending and scale, and when the “moat” you are claiming depends on infrastructure that is expensive just to maintain.
In response to that reality, OpenAI’s strategy is described in the piece as aiming to create a moat too difficult to cross. The company reportedly laid out the “third phase of OpenAI” on Monday, including research into artificial general intelligence and a push toward becoming a “product company.” The “product company” angle matters because it hints at a potential shift in revenue mechanics. If OpenAI launches its own product range, it could become a major competitor to Apple and Google, at least in the sense of going after consumer and platform-like mindshare. The article flags that investors should watch the share prices of Apple and Google closely on Tuesday, because the market may start discounting competitive pressure across the product stack.
This is also why the IPO moment is being framed as part of a “hat trick of mega listings on the cards,” with OpenAI’s filing coming hot on the heels of Anthropic and SpaceX. The sequence matters. These aren’t small floats where investors can nibble and move on. They are ultra-large, highly valued companies that promise to reshape not only investing, but the “entirety of human society,” according to the piece. Whether or not you buy the language, the implication is operationally clear for boards: the capital markets are effectively staging a recurring referendum on the AI business model.
And it is not happening in a policy vacuum. The coverage includes a separate but relevant background thread: UK macroeconomic signals are being interpreted as more resilient than feared, including an upward revision in PMI business indices last week. It also notes that an MPC member, Greene, said she would consider voting for a hike at the next Bank of England meeting later this month. Meanwhile, UK-focused attention also includes the mention of “UK investigating Paramount-Warner Bros merger” in the business live framing of the story.
Now connect the dots. Mega listings demand investor appetite, and investor appetite is sensitive to rates, risk tolerance, and regulatory clarity. Even if the AI story is dominating headlines, executives still operate in the real economy where central banks, macro data, and competition policy can shape funding costs, valuation multiples, and how quickly big companies can scale through deals. For tech leaders and investors, the second-order question becomes: will capital keep rewarding AI capex at these levels, or will IPO demand start to thin when the market forces a more disciplined view of margins and durability?
For peers watching from the sidelines, the stakes are straightforward and immediate. OpenAI’s filing is a public stress test of demand for a company with infrastructure spending estimated at more than $100 billion a year and a valuation already at $850bn. Anthropic being valued ahead at $965bn adds to the pressure, because it suggests investors are actively deciding between different AI strategies, not just buying “AI” as a theme. If the IPO market digests OpenAI smoothly, the next wave of listings gets easier. If it stumbles, boards across AI infrastructure and AI-native products will feel the hit, because the capital window can close fast.
This story's Key Insights and Take-aways are locked.
Create a free account to unlock Executive Actions for one credit.
Register to UnlockAlways free for Executives Club members. Join the Club
More in Business
OpenAI files for an IPO at $852B, signaling it may list sooner than later
The ChatGPT maker’s filing joins Anthropic’s AI listing wave and turns “someday” into a real timing option.

Abbott wins CE Mark for dual glucose-ketone sensing tech in diabetes
The first dual glucose-ketone sensing technology just cleared EU regulators, bringing new monitoring capability closer to market.

Secretlab CEO Ian Ang goes anti-copycat, spends $2M on proprietary materials, and shrugs at AI
Patents, bespoke manufacturing, and a clear line on copying and AI pressure as Secretlab launches the Atlas at $499.
